permethrin has been researched along with Liver Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, SM; Lake, BG; Yamada, T | 1 |
Cohen, SM; Kikumoto, H; Kondo, M; Lake, BG; Osimitz, TG; Yamada, T | 1 |
Boorman, GA; Cullen, JM; Freshwater, L; Hardisty, JF; Maronpot, RR; Quist, EM; Remick, AK; Swenberg, JA | 1 |
Cohen, SM; Kondo, M; Lake, BG; Miyata, K; Nagahori, H; Osimitz, TG; Sumida, K; Yamada, T | 1 |
1 review(s) available for permethrin and Liver Neoplasms
Article | Year |
---|---|
Evaluation of the human hazard of the liver and lung tumors in mice treated with permethrin based on mode of action.
Topics: Adenoma; Animals; Female; Humans; Liver; Liver Neoplasms; Lung Neoplasms; Male; Mice; Permethrin; PPAR alpha; Rats; Rats, Wistar | 2022 |
3 other study(ies) available for permethrin and Liver Neoplasms
Article | Year |
---|---|
An Evaluation of the Human Relevance of the Liver Tumors Observed in Female Mice Treated With Permethrin Based on Mode of Action.
Topics: Animals; Benzoates; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cytochrome P-450 Enzyme System; Female; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Insecticides; Liver Neoplasms; Mice; Permethrin; PPAR alpha; Rats, Wistar; Risk Assessment; Sex Factors; Species Specificity | 2020 |
Reevaluation of Hepatocellular Neoplasms in CD-1 Mice from a 2-year Oral Carcinogenicity Study with Permethrin.
Topics: Administration, Oral; Animals; Carcinogenicity Tests; Carcinogens; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice, Inbred Strains; Permethrin; Sex Factors | 2019 |
Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse.
Topics: Animals; Carcinogens; Cell Proliferation; Cytochrome P-450 CYP4A; Dose-Response Relationship, Drug; Enzyme Activation; Female; Hepatocytes; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Permethrin; PPAR alpha | 2019 |